No Data
No Data
Insider Sale: CHIEF MEDICAL OFFICER of $ANNX Sells 5,521 Shares
Annexon Biosciences CEO Makes Significant Stock Move
Annexon's ANX007 Shows Significant Retinal Protection In Geographic Atrophy In Phase 2 Trial
Annexon Announces Presentations Highlighting ANX007 Functional and Structural Differentiation in Geographic Atrophy at the Macula Society 48th Annual Meeting
BofA Securities Maintains Annexon(ANNX.US) With Buy Rating, Maintains Target Price $12
Analysts' Top Healthcare Picks: Annexon Biosciences (ANNX), Immunovant (IMVT)
Unlock the Full List